27.11.2012 Views

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information<br />

University of Oulu,<br />

Finland<br />

University of<br />

South Florida<br />

University of<br />

Wisconsin<br />

Zeneca<br />

LifeScience<br />

Molecules (now<br />

AstraZeneca)<br />

RESEARCH & DEVELOPMENT: Recombinant collagens and gelatin<br />

Anti-fibrotic therapeutics<br />

Wound repair/tissue engineering<br />

recombinant collagen research and<br />

license agreement<br />

4/94<br />

CTGF license agreement 6/95<br />

collagen biosynthesis research and<br />

license agreement<br />

recombinant human process<br />

collagen<br />

development/<br />

scale-up<br />

PRODUCTS IN DEVELOPMENT: Name Status<br />

FG-3019 (patients with diabetic<br />

nephropathy)<br />

in Phase Ib clinicals<br />

FG-3019 (patients with idiopathic<br />

pulmonary fibrosis)<br />

completed Phase I<br />

FG-3019 (patients with pancreatic cancer) IND filed<br />

FG-2216 for anemia in Phase II clinicals<br />

FG-4592 for iron processing deficiency in Phase I clinicals<br />

FG-5017 - cosmetic dermal filler to begin pivotal efficacy and<br />

safety trial in 2006<br />

FG-4539 for ischemic disease in preclinicals<br />

FG-5016 completed safety study<br />

FG-5009 completed safety study<br />

First Link (UK) Ltd.<br />

1, Valepits Road, Garretts Green<br />

Birmingham B33 0TD, UK<br />

Phone: +44 121 783 8139; Fax: +44 121 786 2747<br />

E-mail: info.firstlink@virgin.net<br />

KEY PERSONNEL: Mick Terry; Director<br />

Dr. Yvette Goward; Director and Company Secretary<br />

EMPLOYEES: 2 employees, 1 Ph.D.<br />

HISTORY: Formed by original management of Advanced Protein Products Ltd. (1995)<br />

FACILITIES: 5,000 sq. ft. headquarters<br />

2,000 sq. ft. R&D facilities<br />

3,000 sq. ft. manufacturing facilities<br />

STOCK-FINANCIAL HISTORY: Privately held<br />

BUSINESS STRATEGY: Research, develop, manufacture, and supply in field of biological chemicals,<br />

especially contract manufacturing<br />

RESEARCH & DEVELOPMENT: Large-scale media for mammalian cell culture<br />

Contract process development<br />

Develop culture media for transplantation of natural and artificial organs<br />

PRODUCTS ON MARKET: High-purity bovine serum albumin and porcine serum albumin<br />

Density gradient media for cell separation<br />

Native and recombinant growth factors<br />

Sera and proteins for cell culture and research<br />

Copyright ©2006 AHC Media ® 165<br />

4/96<br />

3/99

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!